摘要
目的:探讨我国人细小病毒B19感染引起的相关疾病谱.方法:用聚合酶链反应(PCR)技术及原位杂交技术对66例先天性心脏病(CHD)心肌组织标本及108例血小板减少性紫癜(TP)、47例急性再生障碍性贫血(AAA)、5例传染性红斑(EI)及40例缺铁性贫血(IDA)患儿的外周血、骨髓标本进行了B19-DNA检测,并随机对其中23例B19-DNA阳性标本作巨细胞病毒(CMV)、单纯疱疹病毒(HSV)、EB病毒(EBV)及弓形体(TOX)-DNA的检测.结果:①上述疾病中B19-DNA的总阳性检出率为26.3%(70/266),其中EI,AAA,ITP和CHD病例中B19-DNA的阳性率分别为100%(5/5),25.5%(12/47)及38.0%(41/108)和18.2%(12/66);②23例B19-DNA阳性病例中,AAA,TP及CHD的标本CMV-DNA的检出率分别为10.0%(1/10),20.0%(1/5)及40.0%(2/5).结论:我国HPVB19病毒感染可引起EI,AAA和急性血小板减少性紫癜,并可能为CHD的重要致病因子之一.
AIM: To explore the disease spectrums related to human parvovirus B19 (HPV B19) infection in China. METHODS: By using nested polymerase chain reaction assay and in situ hybridisation, HPVB19 DNA was detected in cardiac tissue from 66 patients with congenital heart disease (CHD), in peripheral blood and bone marrow from 47 patients with acute aplastic anemia (AAA), 108 with thrombocytopenic purpura (TP), 5 with erythema infectiosum (EI), and 40 with iron deficiency anemia (IDA). Meanwhile, cytomegalovirus (CMV), herpes simplex virus (HSV), EpsteinBarr virus (EBV) and toxoplasma (TOX) were also detected in 23 randomly selected cases of HPVB19 positive. RESULTS: The total positive rate of HPV B19 was 26.3% (70/266). The HPVB19 positive rates in EI, AAA, TP and CHD were 100% (5/5), 25.5% (12/47), 38.0% (41/108) and 18.2% (12/66) respectively. The CMV positive rates in the 23 cases of HPVB19 positive specimens of AAA, TP and CHD were 10.0% (1/10), 20.0% (1/5), 40.0% (2/5) respectively. ZCONCLUSION: HPVB19 infection may cause EI,AAA and TP,and may be one of the pathogens of CHD.
出处
《第四军医大学学报》
1999年第6期495-498,共4页
Journal of the Fourth Military Medical University
基金
国家自然科学基金
关键词
细小病毒感染
细小病毒B19
疾病谱
聚合酶链反应
parvovirus infections
parvovirus B19
diseases spectrum
polymerase chain reaction
in situ hybridisation